JW Shinyak KRX:067290KOSDAQ

JW신약 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days1
DART filings, 7 days0
Articles tracked7since Sep 11

In Q2 2026, JW Shinyak reported revenue of ₩21.5bn, up 9.4% year on year, and operating profit of ₩3.6bn. JW Shinyak (JW신약) appeared in 1 Korean news article and 0 DART filings over the past seven days. Coverage peaked on Oct 20 with 1 article.

JW Shinyak quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩21.5bn+9.4%₩3.6bn
margin 16.6%
₩3.6bn
Q1 2026₩21.4bn+8.8%₩2.9bn
margin 13.5%
₩2.7bn
Q4 2025 derived₩21.1bn+31.2%₩1.4bn
margin 6.7%
₩2.0bn
Q3 2025₩20.6bn-34.7%₩2.7bn
margin 13.1%
₩2.0bn
Q2 2025₩19.7bn-8.9%₩2.7bn
margin 13.5%
₩3.1bn
Q1 2025₩19.7bn-17.4%₩667m
margin 3.4%
₩8.6bn
Q4 2024 derived₩16.1bn-34.3%−₩2.9bn
margin −18.0%
−₩3.5bn
Q3 2024₩31.5bn+13.5%₩8.1bn
margin 25.8%
₩5.9bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

JW Shinyak top stories 2 weeks, by number of outlets

  1. 1
    JW신약 주가, 10월 20일 장중 2,565원 1.58% 상승
    1 outlets · 1 articlesFirst report Oct 20 14:04 중앙이코노미뉴스
  2. 2
    JW신약 주가, 10월 29일 장중 2,320원 2.32% 하락
    1 outlets · 1 articlesFirst report Oct 29 14:06 중앙이코노미뉴스

Latest JW Shinyak news Korean headlines